Premium
Enlivex Ltd (ENLV)
NASDAQ
Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Enlivex Ltd., together with its subsidiaries, operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel. It offers AllocetraTM, a cell therapy designed to restore macrophage homeostasis, as well as develops AllocetraTM intra-articular injection for the treatment of knee o... Enlivex Ltd., together with its subsidiaries, operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel. It offers AllocetraTM, a cell therapy designed to restore macrophage homeostasis, as well as develops AllocetraTM intra-articular injection for the treatment of knee osteoarthritis, which is in phase 1/2 trial; intra-articular AllocetraTM in osteoarthritis of the temporomandibular joint (TMJ); and Allocetra-OTS for the treatment of organ failure in adult sepsis patients, which is in phase 2. Enlivex Ltd. was formerly known as Enlivex Therapeutics Ltd. and changed its name to Enlivex Ltd. in February 2026. The company was founded in 2005 and is headquartered in Ness Ziona, Israel. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.1613 | -19.4337349398 | 0.83 | 0.855 | 0.6639 | 330244 | 0.76682298 | CS |
| 4 | -0.0912 | -12.0015791552 | 0.7599 | 0.899399 | 0.66 | 432316 | 0.77617986 | CS |
| 12 | -0.4313 | -39.2090909091 | 1.1 | 1.32 | 0.66 | 635052 | 0.9709664 | CS |
| 26 | -0.3713 | -35.7019230769 | 1.04 | 1.32 | 0.66 | 516244 | 0.97058839 | CS |
| 52 | -0.2713 | -28.8617021277 | 0.94 | 2.34 | 0.66 | 1322285 | 1.03822613 | CS |
| 156 | -1.9713 | -74.6704545455 | 2.64 | 4.59 | 0.66 | 511741 | 1.12786488 | CS |
| 260 | -8.9013 | -93.012539185 | 9.57 | 13.95 | 0.66 | 340823 | 1.864929 | CS |
Transactions différées
Pour obtenir des transactions en temps réel, améliorez votre compte
Passer à la version en temps réel| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
